Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma
Condition(s):T-cell LymphomaLast Updated:February 12, 2013Completed
Hide Studies Not Open or Pending
Condition(s):T-cell LymphomaLast Updated:February 12, 2013Completed
Condition(s):T-cell LymphomaLast Updated:October 25, 2023Terminated
Condition(s):Peripheral T Cell LymphomaLast Updated:November 18, 2023Recruiting
Condition(s):T-Cell LymphomaLast Updated:December 20, 2023Recruiting
Condition(s):T Cell LymphomaLast Updated:September 19, 2016Completed
Condition(s):Peripheral T-Cell LymphomaLast Updated:December 13, 2023Recruiting
Condition(s):Peripheral T-cell LymphomaLast Updated:October 5, 2016Completed
Condition(s):T Cell LymphomaLast Updated:October 28, 2022Completed
Condition(s):Peripheral T-cell LymphomaLast Updated:October 14, 2019Completed
Condition(s):Relapsed or Refractory T-cell LymphomasLast Updated:March 20, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.